Abbvie Stock Forecast & Predictions: 1Y Price Target $170.86 | Buy or Sell NYSE: ABBV 2024 (2024)

FAQs

What is AbbVie stock price prediction for 2024? ›

AbbVie Stock Price Forecast 2024-2025

The forecasted AbbVie price at the end of 2024 is $221 - and the year to year change +43%. The rise from today to year-end: +27%.

Stock Price Forecast

The 11 analysts with 12-month price forecasts for AbbVie stock have an average target of 182.18, with a low estimate of 150 and a high estimate of 196. The average target predicts an increase of 8.51% from the current stock price of 167.89.

Is ABBV a Buy, Sell or Hold? AbbVie has a conensus rating of Strong Buy which is based on 12 buy ratings, 3 hold ratings and 0 sell ratings. The average price target for AbbVie is $186.31.

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for AbbVie stock to perform well in the short-term period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Abbvie Inc quote is equal to 166.410 USD at 2024-04-20. Based on our forecasts, a long-term increase is expected, the "ABBV" stock price prognosis for 2029-04-11 is 235.704 USD. With a 5-year investment, the revenue is expected to be around +41.64%. Your current $100 investment may be up to $141.64 in 2029.

The ABBV stock shareholders received the last dividend payment of $1.55 per share on May 15, 2024 . When is AbbVie Inc.'s next dividend payment date? AbbVie Inc.'s next dividend payment will be on May 15, 2024 . Does AbbVie Inc. have sufficient earnings to cover its dividends?

The split took place on January 1, 2013, and AbbVie was listed on the NYSE the next day with the ticker ABBV.

Abbott Laboratories stock prediction for 1 year from now: $ 117.20 (8.89%) Abbott Laboratories stock forecast for 2025: $ 120.30 (11.81%) Abbott Laboratories stock prediction for 2030: $ 210.20 (95.35%)

The average twelve-month price prediction for AbbVie is $177.43 with a high price target of $196.00 and a low price target of $150.00.

What are the threats to AbbVie? ›

Threats. Regulatory and Legal Challenges: AbbVie operates in a highly regulated industry, and any changes in healthcare laws or policies could adversely affect its business.

The stock debuted on Jan. 2, 2013, as a spin-off from Abbott Labs, and it was priced at $35. If you'd invested $25,000 into the company then, that would have secured you about 714 shares of the healthcare business.

Is AbbVie stock a Buy, Sell or Hold? AbbVie stock has received a consensus rating of buy. The average rating score is and is based on 35 buy ratings, 8 hold ratings, and 3 sell ratings.

According to the ETF Finder at ETF Channel, AbbVie Inc is a member of the iShares S&P 1500 Index ETF (ITOT), and is also an underlying holding representing 1.73% of the SPDR S&P Dividend ETF (SDY), which holds $356,585,309 worth of ABBV shares. AbbVie Inc (Symbol: ABBV) made the "Dividend Channel S.A.F.E.

Abbvie Stock Edges Lower After CVS Says It Will Drop Humira From Some Coverage. Shares of Abbvie traded lower after CVS Health said it will remove anti-inflammatory drug Humira from some of its lists of covered drugs and add lower-cost options.

Wall Street analysts' consensus estimates predict 3.6% earnings growth and 3.5% revenue growth for S&P 500 companies in the first quarter. Analysts project full-year S&P 500 earnings growth of 11.0% in 2024, but analysts are more optimistic about some market sectors than others.

Target Stock Price Forecast 2024-2025

Target price started in 2024 at $142.42. Today, Target traded at $165.34, so the price increased by 16% from the beginning of the year. The forecasted Target price at the end of 2024 is $206 - and the year to year change +45%. The rise from today to year-end: +25%.

Analysts Expect Pfizer Stock to Go Higher

Moreover, even the most bearish of analysts covering Pfizer don't see it dropping any further, as the Street-low target price of $27 is roughly flat with current prices. However, the Street-high target price of $54 implies the stock nearly doubling from these levels.

( ABBV ) pays dividends on a quarterly basis. The next dividend payment is planned on May 15, 2024 . AbbVie Inc. ( ABBV ) has increased its dividends for 10 consecutive years.